Stock Earnings

Question 1

Quels sont les états financiers clés de Rani Therapeutics Holdings Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Rani Therapeutics Holdings Inc a un total d'actifs de $36, un bénéfice net loss de $-30

Question 2

Quels sont les ratios financiers clés pour RANI ?

Accepted Answer

Le ratio de liquidité de Rani Therapeutics Holdings Inc est 1.05, la marge nette est -3,000, les ventes par action sont de $0.03.

Question 3

Comment les revenus de Rani Therapeutics Holdings Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Rani Therapeutics Holdings Inc data is not available.

Question 4

Rani Therapeutics Holdings Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Rani Therapeutics Holdings Inc a un bénéfice net loss de $-30

Question 5

Rani Therapeutics Holdings Inc a-t-elle des passifs ?

Accepted Answer

yes, Rani Therapeutics Holdings Inc a un passif de 34

Question 6

Combien d'actions en circulation Rani Therapeutics Holdings Inc a-t-elle ?

Accepted Answer

Rani Therapeutics Holdings Inc a un total d'actions en circulation de 57.4

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1	1	0	0	2	0
Revenue Growth (YoY)	--	--	--	-100%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	21	23	26	26	27	4
Research & Development	25	26	39	36	26	12
Operating Expenses	50	50	66	63	54	17
Other Non Operating Income (Expenses)	--	--	--	0	0	0
Pretax Income	-52	-56	-67	-63	-53	-16
Income Tax Expense	--	0	0	0	0	0
Net Income	-29	-30	-33	-30	-8	-16
Net Income Growth	-3%	-9%	10%	275%	-50%	-38%
Shares Outstanding (Diluted)	36.54	28.47	25.5	23.82	19.53	48.01
Shares Change (YoY)	39%	12%	7%	22%	-59%	0%
EPS (Diluted)	-0.81	-1.05	-1.33	-1.28	-0.43	-0.35
EPS Growth	-31%	-21%	4%	198%	23%	-36%
Free Cash Flow	-31	-35	-52	-48	-32	-16
Free Cash Flow Per Share	-0.84	-1.22	-2.03	-2.01	-1.63	-0.33
Gross Margin	--	--	--	--	--	--
Operating Margin	-4,900%	-4,900%	0%	0%	-2,550%	0%
Profit Margin	-2,900%	-3,000%	0%	0%	-400%	0%
Free Cash Flow Margin	-3,100%	-3,500%	0%	0%	-1,600%	0%
EBITDA	-48	-48	-66	-63	-51	-16
EBITDA Margin	-4,800%	-4,800%	0%	0%	-2,550%	0%
D&A For EBITDA	1	1	0	0	0	0
EBIT	-49	-49	-66	-63	-51	-16
EBIT Margin	-4,900%	-4,900%	0%	0%	-2,550%	0%
Effective Tax Rate	--	0%	0%	0%	0%	0%

Rani Therapeutics Holdings Inc (RANI) Price